Clinical Trials Directory

Trials / Completed

CompletedNCT07240103

Blood-Interstitial Fluid Glucose Gap

Blood-Interstitial Fluid Glucose Gap: A Novel Indicator for Assessing Metabolic Status and Mortality Risk in Critically Ill Patients

Status
Completed
Phase
Study type
Observational
Enrollment
140 (actual)
Sponsor
Chinese Medical Association · Network
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Metabolic monitoring is fundamental to guiding nutritional therapy in critically ill patients. Although indirect calorimetry is the established gold standard for measuring resting energy expenditure, its routine clinical use is constrained by practical challenges, including procedural complexity, time-intensive nature, significant cost, and limited feasibility in patients on advanced life support, such as extracorporeal membrane oxygenation (ECMO). Dysregulation of glucose metabolism is common in this population, characterized not only by absolute dysglycemia but also-and perhaps more critically-by impairments in the efficiency of glucose transport and utilization across the microcirculatory continuum (from arterial blood, through the interstitial space, to venous return). This study seeks to examine the relationship between novel dynamic metrics-such as the arterio-interstitial glucose gradient-and key clinical parameters, including energy expenditure, organ function, and patient outcomes. Our objective is to assess the utility of these measures as minimally invasive, real-time biomarkers of metabolic state in critical illness.

Detailed description

This prospective observational study aims to investigate the association between blood-interstitial fluid glucose concentration differences and resting energy expenditure, organ function, and clinical outcomes in critically ill patients, while also exploring potential factors influencing these glucose concentration differences.

Conditions

Timeline

Start date
2023-07-13
Primary completion
2024-03-13
Completion
2025-10-01
First posted
2025-11-20
Last updated
2025-11-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07240103. Inclusion in this directory is not an endorsement.